Related Experiment Video
Updated: Jun 17, 2026
08:05
A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
Harm reduction therapy: a practice-friendly review of research
Diane E Logan1, G Alan Marlatt
1Department of Psychology, University of Washington, Box 351629, Seattle, WA 98195, USA. logande@uw.edu
Journal of Clinical Psychology
|January 6, 2010
Summary
Harm reduction strategies effectively minimize risks associated with various behaviors, including substance use. These evidence-based interventions offer valuable alternatives for individuals not pursuing complete abstinence.
Area of Science:
- Behavioral Science
- Public Health
- Addiction Medicine
Background:
- Harm reduction, initially focused on substance use, now addresses diverse behavioral disorders.
- It offers practical strategies for managing problematic behaviors beyond complete abstinence.
Purpose of the Study:
- To review empirical research on harm reduction practices across various populations and behaviors.
- To evaluate the effectiveness and safety of harm reduction interventions.
Main Methods:
- Systematic review of peer-reviewed controlled trials.
- Analysis of interventions for alcohol use, nicotine dependence, opioid use disorder, and other behavioral issues.
Main Results:
- Dozens of studies support the efficacy of harm reduction interventions.
- No significant iatrogenic effects were observed across reviewed studies.
- Harm reduction is effective for diverse clients and disorders.
Conclusions:
- Harm reduction provides essential tools for clinicians when abstinence is not feasible.
- These interventions successfully reduce negative consequences of behaviors.
- Empirical evidence supports the broad application of harm reduction principles.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:27Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...